Exercise does not slow cognitive decline in dementia patients

Exercising does not slow mental impairment in people with dementia, and may even worsen symptoms, according to a study which contradicts the belief that physical exercise can slow cognitive decline.

Although the exercise programme improved physical fitness, it cannot be recommended as a treatment option for cognitive impairment in dementia, researchers said.

Nearly 47.5 million people worldwide have dementia and the view that exercise might slow cognitive decline has gained widespread popularity.

However, recent reviews of trials of exercise training in people with dementia have shown conflicting results.

Researchers including those from University of Oxford and University of Warwick in the UK decided to estimate the effect of a moderate to high intensity aerobic and strength exercise training programme on cognitive impairment and other outcomes in people with dementia.

The trial involved 494 people with mild to moderate dementia (average age 77 years) living in the community across 15 regions of England.

General health and fitness was assessed at the start of the study and participants were randomly assigned to either a supervised exercise and support programme (329 patients) or to usual care (165 patients).

The programme consisted of 60-90 minute group sessions in a gym twice a week for four months, plus home exercises for one additional hour each week with ongoing support.

The primary outcome was an Alzheimer's disease assessment score (ADAS-cog) at 12 months. Other outcomes included activities of daily living, number of falls, and quality of life.

Compliance with exercise was good and participants were assessed again at six and 12 months.

After taking account of potentially influential factors, the researchers found that cognitive impairment declined over the 12-month follow-up in both groups.

The exercise group showed improved physical fitness in the short term, but higher ADAS-cog scores at 12 months (25.2 v 23.8) compared with the usual care group, indicating worse cognitive impairment.

However, the average difference was small and clinical relevance was uncertain.

No differences were found in secondary outcomes, including number of falls and quality of life, or after further analyses to test the strength of the results.

The researchers point to some trial limitations. For example, participants and carers knew which group they were in, and the period of structured exercise may have been too short to produce positive benefits. However, strengths over previous trials included a substantially larger sample size and high levels of follow-up.

"This trial suggests that people with mild to moderate dementia can engage and comply with moderate to high intensity aerobic and strengthening exercise and improve physical fitness," researchers said.

"These benefits do not, however, translate into improvements in cognitive impairment, activities in daily living, behaviour, or health related quality of life," they said.

"The results are somewhat surprising as we would anticipate that exercise would have positive effects," said James Pickett, Head of Research and Development at Alzheimer's Society.

"The study finds that whilst it is possible for interested people with Alzheimer's disease to engage in a robust supervised exercise program, this does not appear to delay cognitive decline and does not improve any other outcome besides physical fitness," said Brendon Stubbs, Post-doctoral Research Physiotherapist at King's College London.

"The search for effective lifestyle interventions that can delay cognitive decline in dementia must continue," said Stubbs.